Enveric Biosciences Announces Reverse Stock Split
Common Stock Will Begin Trading on a Split-Adjusted Basis on October 28, 2025 CAMBRIDGE, Mass. — Enveric Biosciences (NASDAQ: ENVB) ("Enveric" or the "Company"), a biotechnology company advancing next-generation neuroplastogenic small molecules to address psy
(Financial Post, 2025-10-23T12:07:19Z)